Error message

The page you requested does not exist. For your convenience, a search was performed using the query trials scope 2.

Search results

  1. Professor James Brenton

    ... in resistance has been to develop novel phase II clinical trials with sequential collection and profiling of ovarian cancer tissues ...

  2. Dr Massimiliano di Pietro

    ... recent multi-centre studies led by our group (TIME and ACE-B trials) have demonstrated that it is possible to increase diagnostic accuracy ...

  3. Dr Michael Gattens

    ... am principal investigator for a number of national leukaemia trials, and coinvestigator for trials of new haemophilia factor concentrates in paediatric haemophilia ...

  4. Dr Phil Jewsbury

    ... pre-clinical candidate drugs to proof-of-concept Phase 2 trials. Currently a Senior Project Director in AstraZeneca Oncology ...

  5. Dr Richard Baird

    Early phase clinical trials, including expertise in: - first-in-human studies & drug combination trials - new small molecule & antibody therapeutics - development of ... cancer therapeutics. Investigator-initiated clinical trials funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer ...

  6. Professor Richard Gilbertson

    ... Program and founding Director of the Molecular Clinical Trials Core before being appointed as the Comprehensive Cancer Center Director, ...

  7. Mr Richard Skells

    ... studies coordinated by CCTU and Cambridge Cancer Trials Centre. ...

  8. Professor Robert Rintoul

    ... at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration. He is co-lead of the CRUK Cambridge Centre Thoracic ... Rintoul’s research is focused around clinical trials, translational research and tissue banking in malignant mesothelioma and ...

  9. Dr Robert Thomas

    ... completed and published a number of national research trials including; an evaluation of the impact of exercise in relation to ...

  10. Dr Tim Mitchell

    ... CRT Pioneer Fund. This programme will start Phase 1 clinical trials at the Royal Marsden Hospital in June 2016. SKIL® (Sareum Kinase ...

  11. Professor Clemens Kaminski

    Using microscopic techniques such as Fluorescent Resonance Energy Transfer (FRET), Fluorescence Lifetime Imaging Microscopy (FLIM) and dynamic imaging we can study chemistry and molecular transport directly within the living cell. A major effort is...

  12. Professor Ernest Laue

    ... methods, in particular computational methods, to extend the scope of NMR spectroscopy for the study of the structure of larger ...

  13. Professor Andrea Brand

  14. Dr Alison Schuldt

  15. Mr Adam Palmer

  16. Dr Avgi Andreou

  17. Mr Aws Al-deka

  18. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

  19. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  20. Miss Ariella Stewart

  21. Miss Anita Balakrishnan

  22. Mrs Abigail Redman

  23. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis

    ... including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Embase to 3 April 2019, and the NHS Economic ... economic evaluations are needed, in which a broader scope of costs (both direct and indirect) and outcomes should be included. ...

  24. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis

    ... including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and Embase to 3 April 2019, and the NHS Economic ... economic evaluations are needed, in which a broader scope of costs (both direct and indirect) and outcomes should be included. ...

Pages